Please or to access all these features

Feminism: Sex and gender discussions

NHS England and NHS Improvement - Puberty blockers update

40 replies

ItsAllGoingToBeFine · 15/04/2021 15:00

www.england.nhs.uk/commissioning/spec-services/npc-crg/gender-dysphoria-clinical-programme/update-following-recent-court-rulings-on-puberty-blockers-and-consent/

Summary: children already on PBs can continue, with parental consent.

New patients currently require court order to start, but this will be replaced by a "decision group" of experts which will examine the decision making processes.

OP posts:
R0wantrees · 15/04/2021 17:04

a new independent multidisciplinary professional review group will be established to confirm decision-making has followed a robust process.

The MDT is a well established process for reviewing decisions in cancer care.

highame · 15/04/2021 16:59

I read it as independent. Given the bad press, I imagine the NHS is going to use the term 'robust' when looking at the steps they take. At least I bloody well hope they will

Tibtom · 15/04/2021 16:36

Not 'independent' at all then?

PurpleWh1teGreen · 15/04/2021 16:33

The members of the group will immediately find themselves the focus of intense lobbying and threats and criticisms it they disagree with TRAs. This is also likely to affect who would be happy to join.

I agree with you about pressure from TRAs but will also now be also be more pressure to be cautious without good reason to intervene. Not to mention scrutiny which was missing previously and legal weight.

The MD team will be people involved in the young persons care, I don't read it as being a separate panel.

Tibtom · 15/04/2021 16:26

The members of the group will immediately find themselves the focus of intense lobbying and threats and criticisms it they disagree with TRAs. This is also likely to affect who would be happy to join.

R0wantrees · 15/04/2021 16:23

The make-up of the group and who has voting rights is all important.

This ^^

EmbarrassingAdmissions · 15/04/2021 16:21

This is a much needed interim measure in order to Safeguard the children previously seen only by GIDS specialists. Providing of course these experts come from without a gender ideology framework and are free to apply their professional expertise in making a holistic assessment.

The make-up of the group and who has voting rights is all important.

R0wantrees · 15/04/2021 15:51

As an interim measure, and in direct response to the Court’s suggestion that additional safeguards may be warranted, a new independent multidisciplinary professional review group will be established to confirm decision-making has followed a robust process.

This group will be comprised of health and care professionals with expertise in child development, neurodevelopment and mental health, assessing capacity and consent, and safeguarding processes.

This is a much needed interim measure in order to Safeguard the children previously seen only by GIDS specialists. Providing of course these experts come from without a gender ideology framework and are free to apply their professional expertise in making a holistic assessment.

PurpleWh1teGreen · 15/04/2021 15:27

It's not reasonable for every decision to be referred to court though and the proposed process includes MH professionals and will be a lot more open than previous practice.

As an interim measure, and in direct response to the Court’s suggestion that additional safeguards may be warranted, a new independent multidisciplinary professional review group will be established to confirm decision-making has followed a robust process.

This group will be comprised of health and care professionals with expertise in child development, neurodevelopment and mental health, assessing capacity and consent, and safeguarding processes. The review group will ensure:

the Tavistock’s GIDS has carried out an enhanced clinical review of each patient;
there has been a robust process for providing parental consent and child assent;
adequate information, including on the risks and benefits of puberty blockers and on the limited available evidence such that the court has described the treatment as ‘experimental’, has been provided to both patient and parent(s);
the clinical process for forming a prescribing recommendation followed good practice guidelines;
any relevant needs of the patient, and what this may mean for their wider healthcare, has been fully explored.

I think we can assume this will be monitored very carefully with outcomes tracked too.

AnyOldPrion · 15/04/2021 15:17

So rather than going to court for decisions, GIDS will now take the decision with parental consent (which they stated they wouldn’t do) and then the process will be assessed by a review group.

Unless the review group is wholly chosen from parties which are not influenced by GIDS and their policies or the lobby groups that have influenced GIDS, then I have to wonder whether it will provide any useful improvement to the safeguarding procedures that were so noteably absent when examined in court.

Tibtom · 15/04/2021 15:16

The review group talks about good decision making but still ignores the central point of consent unless they switch to parental consent which it looks like they are despite telling the Bell court they never would.

GNCQ · 15/04/2021 15:13

New patients currently require court order to start, but this will be replaced by a "decision group" of experts
I dread to think exactly who will be on this "decision group".

ItsAllGoingToBeFine · 15/04/2021 15:12

@Tibtom

How do they get to overrule the court of protection who say they are needed to make a decision on behalf of a child? The NHS has no capacity to make decisions for others.
The court said children could not consent. The question of parental consent was not considered as GIDS didn't use that.

So they are going to use parental consent, which the court did not rule on.

OP posts:
Novina · 15/04/2021 15:11

Interesting inclusion:

"The judgment of the Administrative Court, accepted by the Family Division, was that the use of puberty blockers to treat gender dysphoria in children should be considered experimental given the limited evidence of efficacy or long-term effects of the treatment."

Tibtom · 15/04/2021 15:05

How do they get to overrule the court of protection who say they are needed to make a decision on behalf of a child? The NHS has no capacity to make decisions for others.

Swipe left for the next trending thread